Lawrence M Alleva - Net Worth and Insider Trading
Lawrence M Alleva Net Worth
The estimated net worth of Lawrence M Alleva is at least $3 Million dollars as of 2024-04-20. Lawrence M Alleva is the Director of Tesaro Inc and owns about 29,902 shares of Tesaro Inc (TSRO) stock worth over $2 Million. Lawrence M Alleva is the Director of Bright Horizons Family Solutions Inc and owns about 9,362 shares of Bright Horizons Family Solutions Inc (BFAM) stock worth over $977,861. Lawrence M Alleva is also the Director of Adaptimmune Therapeutics PLC and owns about 117,864 shares of Adaptimmune Therapeutics PLC (ADAP) stock worth over $115,118. Besides these, Lawrence M Alleva also holds Mersana Therapeutics Inc (MRSN) , Galera Therapeutics Inc (GRTX) . Details can be seen in Lawrence M Alleva's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Lawrence M Alleva has not made any transactions after 2023-12-01 and currently still holds the listed stock(s).
Transaction Summary of Lawrence M Alleva
Lawrence M Alleva Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Lawrence M Alleva owns 6 companies in total, including Adaptimmune Therapeutics PLC (ADAP) , Mersana Therapeutics Inc (MRSN) , and Bright Horizons Family Solutions Inc (BFAM) among others .
Click here to see the complete history of Lawrence M Alleva’s form 4 insider trades.
Insider Ownership Summary of Lawrence M Alleva
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ADAP | Adaptimmune Therapeutics PLC | 2020-06-09 | director |
| MRSN | Mersana Therapeutics Inc | 2020-06-01 | director |
| BFAM | Bright Horizons Family Solutions Inc | 2023-12-01 | director |
| GRTX | Galera Therapeutics Inc | 2021-06-01 | director |
| TSRO | Tesaro Inc | 2019-01-22 | director |
| SYBX | Synlogic Inc | 2015-09-30 | director |
Lawrence M Alleva Latest Holdings Summary
Lawrence M Alleva currently owns a total of 5 stocks. Among these stocks, Lawrence M Alleva owns 29,902 shares of Tesaro Inc (TSRO) as of June 12, 2018, with a value of $2 Million and a weighting of 67.11%. Lawrence M Alleva owns 9,362 shares of Bright Horizons Family Solutions Inc (BFAM) as of December 1, 2023, with a value of $977,861 and a weighting of 29.28%. Lawrence M Alleva also owns 117,864 shares of Adaptimmune Therapeutics PLC (ADAP) as of June 9, 2020, with a value of $115,118 and a weighting of 3.45%. The other 2 stocks Mersana Therapeutics Inc (MRSN) , Galera Therapeutics Inc (GRTX) have a combined weighting of 0.16% among all his current holdings.
Latest Holdings of Lawrence M Alleva
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSRO | Tesaro Inc | 2018-06-12 | 29,902 | 74.96 | 2,241,454 |
| BFAM | Bright Horizons Family Solutions Inc | 2023-12-01 | 9,362 | 104.45 | 977,861 |
| ADAP | Adaptimmune Therapeutics PLC | 2020-06-09 | 117,864 | 0.98 | 115,118 |
| MRSN | Mersana Therapeutics Inc | 2020-06-01 | 1,085 | 3.25 | 3,526 |
| GRTX | Galera Therapeutics Inc | 2021-06-01 | 10,370 | 0.18 | 1,909 |
Holding Weightings of Lawrence M Alleva
Lawrence M Alleva Form 4 Trading Tracker
According to the SEC Form 4 filings, Lawrence M Alleva has made a total of 0 transactions in Tesaro Inc (TSRO) over the past 5 years. The most-recent trade in Tesaro Inc is the sale of 7,142 shares on June 12, 2018, which brought Lawrence M Alleva around $307,892.
According to the SEC Form 4 filings, Lawrence M Alleva has made a total of 2 transactions in Bright Horizons Family Solutions Inc (BFAM) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Bright Horizons Family Solutions Inc is the sale of 680 shares on December 1, 2023, which brought Lawrence M Alleva around $60,241.
According to the SEC Form 4 filings, Lawrence M Alleva has made a total of 1 transactions in Adaptimmune Therapeutics PLC (ADAP) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Adaptimmune Therapeutics PLC is the acquisition of 12,900 shares on June 9, 2020, which cost Lawrence M Alleva around $24,381.
More details on Lawrence M Alleva's insider transactions can be found in the Insider Trading History of Lawrence M Alleva table.Insider Trading History of Lawrence M Alleva
- 1
Lawrence M Alleva Trading Performance
GuruFocus tracks the stock performance after each of Lawrence M Alleva's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Lawrence M Alleva is 7.02%. GuruFocus also compares Lawrence M Alleva's trading performance to market benchmark return within the same time period. The performance of stocks bought by Lawrence M Alleva within 3 months outperforms 10 times out of 14 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Lawrence M Alleva's insider trading performs compared to the benchmark.
Performance of Lawrence M Alleva
Average Return
5.35%
Outperforming Transactions
50%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 8.73 | 7.02 | 11.28 | 5.35 | 1.75 | 5.49 |
| Relative Return to S&P 500(%) | 7.21 | 0.81 | 0.89 | -14.83 | -11.36 | -5.44 |
Lawrence M Alleva Ownership Network
Ownership Network List of Lawrence M Alleva
Ownership Network Relation of Lawrence M Alleva
Lawrence M Alleva Owned Company Details
What does Adaptimmune Therapeutics PLC do?
Who are the key executives at Adaptimmune Therapeutics PLC?
Lawrence M Alleva is the director of Adaptimmune Therapeutics PLC. Other key executives at Adaptimmune Therapeutics PLC include Chief Medical Officer Elliot Norry , Chief Operating Officer Bertrand William C Jr , and Chief Patient Supply Officer John Lunger .
Adaptimmune Therapeutics PLC (ADAP) Insider Trades Summary
Over the past 18 months, Lawrence M Alleva made no insider transaction in Adaptimmune Therapeutics PLC (ADAP). Other recent insider transactions involving Adaptimmune Therapeutics PLC (ADAP) include a net sale of 115,184 shares made by Adrian Rawcliffe , a net sale of 48,376 shares made by John Lunger , and a net sale of 46,074 shares made by Bertrand William C Jr .
In summary, during the past 3 months, insiders sold 0 shares of Adaptimmune Therapeutics PLC (ADAP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 315,048 shares of Adaptimmune Therapeutics PLC (ADAP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 315,048 shares.
Adaptimmune Therapeutics PLC (ADAP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Adaptimmune Therapeutics PLC Insider Transactions
Lawrence M Alleva Mailing Address
Above is the net worth, insider trading, and ownership report for Lawrence M Alleva. You might contact Lawrence M Alleva via mailing address: 1000 Winter Street, Suite 3300, Waltham Ma 02451.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
